Notas de Prensa  

01 de diciembre de 2003

Amgen Announces Webcast of Conference Call to Provide Financial Guidance for 2004

THOUSAND OAKS, Calif., Dec. 1 -- Amgen (Nasdaq: AMGN), the world´s largest biotechnology company, today announced that it would provide financial guidance for 2004 on a conference call with the investment community on Monday, December 15, 2003, at 2:00 p.m. PST.

Participating in the call from Amgen will be Kevin Sharer, Chairman, Chief Executive Officer, and President, and other members of Amgen´s senior management.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call is expected to last approximately 45 minutes.

This event can be accessed by going to Amgen´s website, , and clicking on Investors, then on Amgen Events. The event will be archived and available for replay for 72 hours after the event.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

CONTACT: Amgen, Thousand Oaks Sabrina Johnson, (805) 447-4587 (media) Cary Rosansky, (805) 447-1060 (investors)

EDITOR´S NOTE: An electronic version of this news release may be accessed via our Web site at . Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Media section of the Web site.


Subir notas de prensa y convocatorias

Próximas convocatorias   

No hay próximas convocatorias
Ver todas


Busca notas de prensa por especialidad médica o enfermedad.

Ver todas


Busca notas de prensa por su fecha de edición.

  Selecciona el año

Copyright © 2020, Farmavet, S.L. Todos los derechos reservados.